Journal article
Long-term rhythm control of drug-refractory atrial fibrillation with “hybrid therapy” incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation
The American journal of cardiology, v 93(5), pp 569-575
01 Mar 2004
PMID: 14996581
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
We evaluated the long-term efficacy, safety, and applicability of a “hybrid” therapy strategy for rhythm control in atrial fibrillation (AF), incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation. One hundred thirteen patients (paroxysmal AF [n = 70], persistent/permanent AF [n = 43]) with refractory symptomatic AF were treated with this strategy and followed for 1 to 81 months (mean 30 ± 23). All-cause mortality, AF recurrences, and progression to permanent AF were monitored and recorded by implanted device data logs. There was no procedural mortality. Rhythm control was achieved in 90% of all patients at 3 and 5 years, with comparable efficacy in subpopulations with paroxysmal (98%), persistent, or permanent AF (87%, p >2). Overall survival was 84% at 3 years and 80% at 5 years, and was higher in patients with paroxysmal AF than in patients with persistent or permanent AF (86% vs 67% at 4 years, p <0.001). Patients with persistent or permanent AF had a greater need for cardioversion (p <0.004) and right atrial ablation (p <0.04) than patients with paroxysmal AF to achieve comparable rhythm control. A hybrid therapy strategy can provide safe and effective long-term rhythm control in patients with drug-refractory AF, and can be implemented in subpopulations presenting with paroxysmal, persistent, or permanent AF.
Metrics
Details
- Title
- Long-term rhythm control of drug-refractory atrial fibrillation with “hybrid therapy” incorporating dual-site right atrial pacing, antiarrhythmic drugs, and right atrial ablation
- Creators
- Nandini Madan - Atlantic Health SystemSanjeev Saksena - Brunswick (United States)
- Publication Details
- The American journal of cardiology, v 93(5), pp 569-575
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pediatrics
- Web of Science ID
- WOS:000220075800009
- Scopus ID
- 2-s2.0-1442348782
- Other Identifier
- 991021838135804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Cardiac & Cardiovascular Systems